VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACTEnact Holdings, Inc.
$45.55$6.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACTQuarterly Financials

Enact Holdings, Inc. (ACT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Enact Holdings, Inc. (ACT) quarterly income statement — complete revenue, gross profit & net income history

ACT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue312.07M311.51M311.45M304.62M306.89M301.93M309.59M298.83M291.59M296.19M299.04M277.52M280.94M276.67M275.07M273.54M269.59M272.88M280.31M277.42M
Revenue Growth %1.69%3.17%0.6%1.94%5.25%1.94%3.53%7.68%3.79%7.06%8.71%1.46%4.21%1.39%-1.87%-1.4%--4.42%-1.42%0.5%
Medical Costs & Claims017.81M88.73M78.09M83.06M81.66M67.84M39.43M72.69M83.5M72.99M50.46M43.36M80.8M17.55M-132K46.91M65.2M92.94M96.65M
Medical Cost Ratio %0%5.72%28.49%25.64%27.07%27.05%21.91%13.19%24.93%28.19%24.41%18.18%15.43%29.2%6.38%-0.05%17.4%23.89%33.16%34.84%
Gross Profit0293.7M222.73M226.53M223.83M220.27M241.75M259.4M218.89M212.69M226.05M227.06M237.58M195.87M257.52M273.67M222.68M207.68M187.37M180.77M
Gross Margin %0%94.28%71.51%74.36%72.93%72.95%78.09%86.81%75.07%71.81%75.59%81.82%84.57%70.8%93.62%100.05%82.6%76.11%66.84%65.16%
Gross Profit Growth %-100%33.33%-7.87%-12.67%2.25%3.56%6.95%14.24%-7.86%8.59%-12.22%-17.03%6.69%-5.69%37.44%51.39%-62.98%3.52%-34.51%
Operating Expenses47.04M70.61M12.9M12.02M12.41M12.42M12.29M24.57M12.97M12.95M12.94M12.91M13.06M13.09M12.88M12.79M12.78M12.81M12.76M14.05M
OpEx / Revenue %15.07%22.67%4.14%3.95%4.04%4.11%3.97%8.22%4.45%4.37%4.33%4.65%4.65%4.73%4.68%4.67%4.74%4.69%4.55%5.06%
Depreciation & Amortization00000000000000000000
Combined Ratio %15.07%28.39%32.63%29.58%31.11%31.16%25.88%21.42%29.38%32.56%28.74%22.84%20.08%33.93%11.06%4.63%22.14%28.59%37.71%39.9%
Operating Income213.38M223.09M209.83M214.5M211.42M207.85M229.46M234.83M205.92M199.74M213.1M214.15M224.51M182.78M244.64M260.89M209.91M194.87M174.61M166.73M
Operating Margin %68.38%71.61%67.37%70.42%68.89%68.84%74.12%78.58%70.62%67.44%71.26%77.16%79.92%66.07%88.94%95.37%77.86%71.41%62.29%60.1%
Operating Income Growth %0.93%7.33%-8.55%-8.66%2.67%4.06%7.67%9.66%-8.28%9.28%-12.89%-17.92%6.96%-6.2%40.11%56.48%-69.9%-0.5%3231%
EBITDA213.38M235.55M222.73M226.8M223.71M220.12M241.75M248.47M218.88M212.69M226.05M227.06M237.58M196.04M257.52M273.67M222.68M207.64M187.37M179.47M
EBITDA Margin %68.38%75.62%71.51%74.45%72.9%72.9%78.09%83.15%75.07%71.81%75.59%81.82%84.57%70.86%93.62%100.05%82.6%76.09%66.84%64.69%
Interest Expense12.37M12.46M12.9M12.3M12.29M12.26M12.29M13.64M12.96M12.95M12.94M12.91M13.06M13.26M12.88M12.79M12.78M12.77M12.76M12.74M
Non-Operating Income0-12.46M-12.9M-12.3M-12.29M-12.26M-12.29M-13.64M-12.96M-12.95M-12.94M-12.91M-13.06M-13.26M-12.88M-12.79M-12.78M-12.77M-12.76M-12.74M
Pretax Income213.38M223.09M209.83M214.5M211.42M207.85M229.46M234.83M205.92M199.74M213.1M214.15M224.51M182.78M244.64M260.89M209.91M194.87M174.61M166.73M
Pretax Margin %68.38%71.61%67.37%70.42%68.89%68.84%74.12%78.58%70.62%67.44%71.26%77.16%79.92%66.07%88.94%95.37%77.86%71.41%62.29%60.1%
Income Tax45.61M45.92M46.33M46.69M45.64M45.12M48.79M51.16M44.93M42.44M48.91M46.13M48.52M38.98M53.66M56.15M45.28M41.34M37.4M35.91M
Effective Tax Rate %21.37%20.59%22.08%21.77%21.59%21.71%21.26%21.78%21.82%21.25%22.95%21.54%21.61%21.33%21.93%21.52%21.57%21.21%21.42%21.54%
Net Income167.77M177.16M163.5M167.81M165.78M162.74M180.67M183.67M160.99M157.31M164.19M168.02M175.99M143.81M190.99M204.74M164.63M153.53M137.21M130.81M
Net Margin %53.76%56.87%52.49%55.09%54.02%53.9%58.36%61.46%55.21%53.11%54.91%60.54%62.64%51.98%69.43%74.85%61.07%56.26%48.95%47.15%
Net Income Growth %1.2%8.86%-9.5%-8.64%2.98%3.45%10.03%9.32%-8.52%9.39%-14.03%-17.93%6.9%-6.34%39.19%56.51%-68.38%-0.58%3337.92%
EPS (Diluted)1.181.221.101.111.081.051.151.161.010.981.021.041.080.881.171.251.010.940.840.80
EPS Growth %9.26%16.19%-4.35%-4.31%6.93%7.14%12.75%11.54%-6.48%11.36%-12.82%-16.8%6.93%-6.38%39.29%56.25%-67.86%-1.18%3325.81%
EPS (Basic)1.181.231.111.121.091.061.161.171.010.991.031.041.080.881.171.261.010.940.840.80
Diluted Shares Outstanding142.63M145.29M148.34M150.73M152.91M154.54M157.02M158.57M160.09M160.9M161.15M162.17M163.18M163.52M163.38M163.22M163.05M162.88M162.85M162.84M